Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 9/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 9/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 8/20 | 0.34 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.32 |
| ▸ | ITGAV | P06756 | 4/20 | 0.32 |
| ▸ | ITGB5 | P18084 | 4/20 | 0.32 |
| ▸ | TOP1 | P11387 | 2/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26762296 | 0.85 | ELANE (0.35) | ELANEHDAC1HDAC6HDAC3ITGB3 | |
| SCHEMBL21137877 | 0.85 | HDAC1 (0.36) | ELANEHDAC1HDAC6HDAC3ITGB3 | |
| SCHEMBL22618831 | 0.83 | ELANE (0.38) | ELANEHDAC1HDAC6HDAC3ITGB3 | |
| SCHEMBL22618794 | 0.82 | ELANE (0.35) | ELANEHDAC1HDAC6HDAC3ITGB3 | |
| SCHEMBL29293293 | 0.80 | ELANE (0.38) | ELANEHDAC1HDAC6HDAC3ITGB3 | |
| SCHEMBL26762430 | 0.80 | ELANE (0.38) | ELANEHDAC1HDAC6HDAC3ITGB3 | |
| SCHEMBL21137618 | 0.80 | HDAC1 (0.36) | ELANEHDAC1HDAC6HDAC3ITGB3 | |
| SCHEMBL22618789 | 0.79 | ELANE (0.35) | ELANEHDAC1HDAC6HDAC3ITGB3 | |
| SCHEMBL26762377 | 0.79 | ELANE (0.37) | ELANEHDAC1HDAC6HDAC3ITGB3 | |
| SCHEMBL22561328 | 0.79 | ELANE (0.37) | ELANEHDAC1HDAC6HDAC3ITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357259-A1 | BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2023-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357259-A1 | BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | DOCK11, PAICS, RHOA | ELANE 3216/4885HDAC1 1777/4885HDAC6 384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.